Literature DB >> 18946086

Competitive nuclear export of cyclin D1 and Hic-5 regulates anchorage dependence of cell growth and survival.

Kazunori Mori1, Etsuko Hirao, Yosuke Toya, Yukiko Oshima, Fumihiro Ishikawa, Kiyoshi Nose, Motoko Shibanuma.   

Abstract

Anchorage dependence of cell growth and survival is a critical trait that distinguishes nontransformed cells from transformed cells. We demonstrate that anchorage dependence is determined by anchorage-dependent nuclear retention of cyclin D1, which is regulated by the focal adhesion protein, Hic-5, whose CRM1-dependent nuclear export counteracts that of cyclin D1. An adaptor protein, PINCH, interacts with cyclin D1 and Hic-5 and potentially serves as an interface for the competition between cyclin D1 and Hic-5 for CRM1. In nonadherent cells, the nuclear export of Hic-5, which is redox-sensitive, was interrupted due to elevated production of reactive oxygen species, and cyclin D1 was exported from the nucleus. When an Hic-5 mutant that was continuously exported in a reactive oxygen species-insensitive manner was introduced into the cells, cyclin D1 was retained in the nucleus under nonadherent conditions, and a significant population of cells escaped from growth arrest or apoptosis. Interestingly, activated ras achieved predominant cyclin D1 nuclear localization and thus, growth in nonadherent cells. We report a failsafe system for anchorage dependence of cell growth and survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946086      PMCID: PMC2613120          DOI: 10.1091/mbc.e08-04-0428

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  54 in total

1.  Ras signals to the cell cycle machinery via multiple pathways to induce anchorage-independent growth.

Authors:  J J Yang; J S Kang; R S Krauss
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 2.  An essential role for free radicals and derived species in signal transduction.

Authors:  H M Lander
Journal:  FASEB J       Date:  1997-02       Impact factor: 5.191

3.  Ectopic expression of cyclin D1 but not cyclin E induces anchorage-independent cell cycle progression.

Authors:  D Resnitzky
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.

Authors:  J A Diehl; F Zindy; C J Sherr
Journal:  Genes Dev       Date:  1997-04-15       Impact factor: 11.361

5.  Dependence of cyclin E-CDK2 kinase activity on cell anchorage.

Authors:  F Fang; G Orend; N Watanabe; T Hunter; E Ruoslahti
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

6.  Anchorage-dependent transcription of the cyclin A gene.

Authors:  A Schulze; K Zerfass-Thome; J Bergès; S Middendorp; P Jansen-Dürr; B Henglein
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

7.  Cell adhesion kinase beta forms a complex with a new member, Hic-5, of proteins localized at focal adhesions.

Authors:  M Matsuya; H Sasaki; H Aoto; T Mitaka; K Nagura; T Ohba; M Ishino; S Takahashi; R Suzuki; T Sasaki
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

8.  Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions.

Authors:  D Weinstat-Saslow; M J Merino; R E Manrow; J A Lawrence; R F Bluth; K D Wittenbel; J F Simpson; D L Page; P S Steeg
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

9.  Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.

Authors:  X Zhu; M Ohtsubo; R M Böhmer; J M Roberts; R K Assoian
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

Review 10.  Anchorage-dependent cell cycle progression.

Authors:  R K Assoian
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

View more
  11 in total

Review 1.  Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.

Authors:  Chenguang Wang; Michael P Lisanti; D Joshua Liao
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

2.  Expression of focal adhesion proteins in the developing rat kidney.

Authors:  Sato Matsuura; Shuji Kondo; Kenichi Suga; Yukiko Kinoshita; Maki Urushihara; Shoji Kagami
Journal:  J Histochem Cytochem       Date:  2011-06-24       Impact factor: 2.479

3.  Paxillin regulated genomic networks in prostate cancer.

Authors:  Xiaoting Ma; Anindita Biswas; Stephen R Hammes
Journal:  Steroids       Date:  2019-07-22       Impact factor: 2.668

4.  Diverse roles for the paxillin family of proteins in cancer.

Authors:  Nicholas O Deakin; Jeanine Pignatelli; Christopher E Turner
Journal:  Genes Cancer       Date:  2012-05

5.  A HIC-5- and KLF4-dependent mechanism transactivates p21(Cip1) in response to anchorage loss.

Authors:  Kazunori Mori; Hiroyuki Hamanaka; Yukiko Oshima; Yuri Araki; Fumihiro Ishikawa; Kiyoshi Nose; Motoko Shibanuma
Journal:  J Biol Chem       Date:  2012-09-24       Impact factor: 5.157

6.  Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Luca Scarsella; Alessandro Colapietro; Ana Jitariuc; Flora Vitale; Francesco Marampon; Enrico Ricevuto; Claudio Festuccia
Journal:  Tumour Biol       Date:  2015-07-29

7.  HIC-5: A Mobile Molecular Scaffold Regulating the Anchorage Dependence of Cell Growth.

Authors:  Motoko Shibanuma; Kazunori Mori; Kiyoshi Nose
Journal:  Int J Cell Biol       Date:  2011-11-17

8.  Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.

Authors:  D T N Shola; H Wang; R Wahdan-Alaswad; D Danielpour
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

9.  ANP32B is a nuclear target of henipavirus M proteins.

Authors:  Anja Bauer; Sebastian Neumann; Axel Karger; Ann-Kristin Henning; Andrea Maisner; Boris Lamp; Erik Dietzel; Linda Kwasnitschka; Anne Balkema-Buschmann; Günther M Keil; Stefan Finke
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

10.  Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.

Authors:  Giovanni Luca Gravina; Andrea Mancini; Alessandro Colapietro; Francesco Marampon; Roberta Sferra; Simona Pompili; Leda Assunta Biordi; Roberto Iorio; Vincenzo Flati; Christian Argueta; Yosef Landesman; Michael Kauffman; Sharon Shacham; Claudio Festuccia
Journal:  Oncotarget       Date:  2017-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.